-
-
mar. 22 nov.1 match
- 20:00 16e de finale
-
mer. 23 nov.5 matchs
- 20:00 16e de finale
- 20:00 16e de finale
- 20:00 16e de finale
- 20:00 16e de finale
- 20:30 16e de finale
-
lun. 5 déc.1 match
- 19:00 16e de finale
-
mar. 7 févr.1 match
- 20:00 8e de finale
-
mar. 14 févr.1 match
- 20:00 8e de finale
-
mer. 15 févr.5 matchs
- 19:00 8e de finale
- 19:00 8e de finale
- 20:00 8e de finale
- 20:00 8e de finale
- 20:00 8e de finale
-
mar. 28 févr.1 match
- 20:30 8e de finale
-

John Holland
06 novembre 1988
Bronx (NY) | Américain
1m98 | Poste : 2 / 3
- Points 2.8
- Rebonds 0.6
- Passes décisives 0.4
Derniers matchs de John Holland
Journée | Adversaire | Ligue | Score | Min | Pts | Reb | Pds | 2R-2T | 3R-3T | T% | LFR-LFT | LF% | RO | RD | IN | BP | CT | EVAL |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
20 |
|
EU-1 | L 71-66 | 5 | 3 | 1 | 0 | 0-1 | 1-1 | 50.0% | 0-0 | - | 1 | 0 | 0 | 0 | 0 | 3 |
15 |
|
ABA L. | W 56-76 | 2 | 0 | 0 | 0 | 0-0 | 0-0 | - | 0-0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
19 |
|
EU-1 | W 92-68 | 7 | 0 | 0 | 0 | 0-2 | 0-0 | 0.0% | 0-0 | - | 0 | 0 | 0 | 0 | 0 | -2 |
18 |
|
EU-1 | L 59-79 | 10 | 0 | 0 | 1 | 0-0 | 0-2 | 0.0% | 0-0 | - | 0 | 0 | 1 | 0 | 0 | 0 |
14 |
|
ABA L. | W 57-80 | 17 | 4 | 1 | 1 | 2-5 | 0-2 | 28.6% | 0-0 | - | 1 | 0 | 0 | 0 | 0 | 1 |
Moyennes en saison régulière
Saison | Equipe | Ligue | MJ | Min | Pts | Reb | Pds | 2R-2T | 3R-3T | T% | LFR-LFT | LF% | Ro | Rd | IN | BP | CT | EVAL |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
07-08 |
|
NCAA | 19 | 24 | 8.9 | 4.3 | 0.9 | 2.1-4.3 | 1.1-3.3 | 42.4% | 1.4-2.1 | 65.0% | 1.3 | 2.9 | 1.4 | 2.0 | 0.4 | 8.7 |
08-09 |
|
NCAA | 21 | 38 | 18.6 | 6.3 | 1.6 | 3.6-6.7 | 2.8-7.1 | 45.9% | 3.1-4.1 | 76.7% | 2.4 | 4.0 | 1.7 | 1.8 | 0.3 | 18.3 |
09-10 |
|
NCAA | 26 | 35 | 18.0 | 6.3 | 1.1 | 4.2-8.7 | 1.5-4.6 | 42.9% | 5.1-6.0 | 84.1% | 1.8 | 4.5 | 1.6 | 1.8 | 0.3 | 16.8 |
10-11 |
|
NCAA | 6 | 33 | 19.3 | 5.7 | 1.2 | 3.3-8.2 | 2.2-6.8 | 36.7% | 6.2-6.8 | 90.2% | 1.0 | 4.7 | 1.5 | 2.8 | 0.2 | 14.8 |
11-12 |
|
FRA-1 | 28 | 30 | 14.3 | 4.7 | 1.8 | 3.1-5.7 | 1.6-3.9 | 49.1% | 3.3-3.9 | 83.6% | 0.9 | 3.8 | 1.3 | 2.3 | 0.2 | 14.5 |
12-13 |
|
SPA-1 | 33 | 24 | 10.4 | 2.8 | 1.4 | 2.3-4.6 | 1.3-4.2 | 41.7% | 1.7-2.0 | 87.7% | 1.2 | 1.6 | 0.7 | 2.0 | 0.1 | 8.0 |
13-14 |
|
FRA-1 | 23 | 27 | 10.9 | 3.2 | 1.3 | 2.1-4.3 | 1.5-4.3 | 41.4% | 2.3-3.0 | 76.8% | 0.4 | 2.8 | 1.3 | 1.0 | 0.1 | 10.0 |
14-15 |
|
TUR-1 | 27 | 28 | 11.7 | 2.8 | 1.3 | 2.4-4.1 | 1.4-4.0 | 46.8% | 2.7-3.4 | 81.3% | 0.5 | 2.3 | 1.0 | 1.6 | 0.1 | 10.4 |
15-16 |
|
USA-2 | 37 | 31 | 16.0 | 3.1 | 2.0 | 4.1-6.7 | 1.6-4.3 | 52.0% | 2.9-3.5 | 85.2% | 0.8 | 2.4 | 1.2 | 1.4 | 0.2 | 15.3 |
16-17 |
|
USA-2 | 35 | 39 | 22.6 | 4.7 | 3.0 | 5.4-9.4 | 2.4-7.1 | 47.1% | 4.7-5.3 | 88.2% | 1.2 | 3.5 | 1.6 | 2.5 | 0.2 | 20.3 |
17-18 |
|
USA-2 | 24 | 33 | 17.9 | 3.6 | 2.7 | 3.4-6.9 | 2.8-7.9 | 42.0% | 2.6-3.5 | 75.9% | 0.6 | 3.0 | 1.6 | 2.3 | 0.1 | 14.2 |
17-18 |
|
USA-1 | 22 | 8 | 2.5 | 1.1 | 0.2 | 0.3-1.0 | 0.5-1.6 | 28.8% | 0.4-0.6 | 69.2% | 0.3 | 0.8 | 0.3 | 0.4 | 0.1 | 1.7 |
18-19 |
|
USA-1 | 1 | 1 | 0.0 | 0.0 | 0.0 | 0.0-0.0 | 0.0-0.0 | -% | 0.0-0.0 | -% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
18-19 |
|
USA-2 | 2 | 28 | 14.0 | 0.0 | 0.5 | 3.5-5.0 | 2.0-7.0 | 45.8% | 1.0-1.0 | 100.0% | 0.0 | 0.0 | 1.0 | 1.5 | 0.0 | 7.5 |
18-19 |
|
USA-2 | 38 | 29 | 15.9 | 3.2 | 2.3 | 2.4-4.9 | 2.4-6.4 | 42.5% | 3.8-4.6 | 84.4% | 0.6 | 2.6 | 1.4 | 2.2 | 0.2 | 13.6 |
18-19 |
|
PR-1 | 19 | 26 | 16.9 | 4.1 | 2.5 | 2.5-4.6 | 3.1-7.3 | 46.7% | 2.8-3.5 | 79.1% | 0.9 | 3.1 | 1.2 | 1.4 | 0.2 | 16.3 |
19-20 |
|
ISR-1 | 12 | 25 | 10.4 | 4.0 | 0.7 | 1.3-2.7 | 1.8-4.4 | 42.4% | 2.7-3.3 | 82.1% | 1.3 | 2.7 | 1.8 | 0.6 | 0.0 | 11.7 |
20-21 |
|
VTB L. | 14 | 22 | 8.8 | 2.8 | 1.9 | 1.4-2.7 | 1.6-4.3 | 42.9% | 1.2-1.3 | 94.4% | 0.7 | 2.1 | 1.2 | 1.3 | 0.1 | 9.4 |
20-21 |
|
PR-1 | 15 | 25 | 12.9 | 2.8 | 2.1 | 1.3-2.9 | 2.8-6.6 | 43.0% | 2.0-2.5 | 81.1% | 0.3 | 2.5 | 0.9 | 1.3 | 0.3 | 11.9 |
21-22 |
|
TUR-1 | 5 | 23 | 14.2 | 2.2 | 2.0 | 1.2-3.0 | 3.4-7.0 | 46.0% | 1.6-1.8 | 88.9% | 0.0 | 2.2 | 0.8 | 0.6 | 0.4 | 13.4 |
22-23 |
|
ABA L. | 14 | 10 | 2.8 | 0.6 | 0.4 | 0.6-1.5 | 0.5-1.4 | 39.0% | 0.0-0.0 | -% | 0.1 | 0.5 | 0.2 | 0.4 | 0.0 | 1.9 |
Moyennes en playoffs
Saison | Equipe | Ligue | MJ | Min | Pts | Reb | Pds | 2R-2T | 3R-3T | T% | LFR-LFT | LF% | Ro | Rd | IN | BP | CT | EVAL |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10-11 |
|
NCAA - MM | 1 | 35 | 19.0 | 2.0 | 0.0 | 4.0-11.0 | 3.0-8.0 | 36.8% | 2.0-2.0 | 100.0% | 0.0 | 2.0 | 0.0 | 1.0 | 0.0 | 8.0 |
11-12 |
|
FRA-1 | 2 | 25 | 11.0 | 3.0 | 3.5 | 1.0-2.0 | 2.0-4.5 | 46.2% | 3.0-3.5 | 85.7% | 0.5 | 2.5 | 2.0 | 3.5 | 0.0 | 12.0 |
15-16 |
|
USA-2 | 2 | 40 | 28.5 | 4.5 | 4.0 | 5.0-7.5 | 5.0-8.5 | 62.5% | 3.5-3.5 | 100.0% | 0.5 | 4.0 | 1.0 | 2.5 | 1.0 | 30.5 |
15-16 |
|
USA-1 | 1 | 1 | 0.0 | 0.0 | 0.0 | 0.0-0.0 | 0.0-1.0 | 0.0% | 0.0-0.0 | -% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 |
16-17 |
|
USA-2 | 2 | 32 | 15.0 | 2.0 | 2.0 | 3.0-5.5 | 2.0-8.0 | 37.0% | 3.0-3.5 | 85.7% | 0.0 | 2.0 | 2.5 | 1.5 | 0.5 | 11.5 |
18-19 |
|
PR-1 | 16 | 30 | 15.3 | 3.4 | 3.6 | 2.1-3.6 | 2.7-7.8 | 42.3% | 2.9-3.6 | 82.5% | 0.6 | 2.8 | 1.5 | 1.3 | 0.1 | 15.3 |
19-20 |
|
ISR-1 PO | 3 | 27 | 12.3 | 4.0 | 1.0 | 3.0-4.7 | 2.0-5.0 | 51.7% | 0.3-0.7 | 50.0% | 0.7 | 3.3 | 2.7 | 0.7 | 0.3 | 14.7 |
20-21 |
|
VTB L. | 8 | 23 | 9.8 | 3.0 | 1.8 | 2.0-2.9 | 1.5-3.8 | 52.8% | 1.3-1.5 | 83.3% | 0.5 | 2.5 | 1.1 | 1.4 | 0.0 | 10.9 |
20-21 |
|
PR-1 | 7 | 33 | 15.6 | 5.6 | 2.3 | 2.3-4.3 | 2.7-7.1 | 43.8% | 2.9-3.3 | 87.0% | 1.7 | 3.9 | 1.9 | 1.0 | 0.4 | 17.9 |
21-22 |
|
TUR-1 | 3 | 22 | 12.7 | 1.7 | 1.3 | 1.3-1.7 | 2.3-5.3 | 52.4% | 3.0-3.3 | 90.0% | 0.3 | 1.3 | 0.0 | 1.3 | 0.0 | 10.7 |
21-22 |
|
PR-1 | 7 | 34 | 18.3 | 4.1 | 2.4 | 2.6-4.9 | 3.9-9.3 | 45.5% | 1.6-2.0 | 78.6% | 1.7 | 2.4 | 1.0 | 1.6 | 0.1 | 16.3 |
Moyennes en compétitions européennes
Saison | Equipe | Ligue | MJ | Min | Pts | Reb | Pds | 2R-2T | 3R-3T | T% | LFR-LFT | LF% | Ro | Rd | IN | BP | CT | EVAL |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11-12 |
|
FEC | 14 | 31 | 16.4 | 5.2 | 2.1 | 4.1-6.2 | 1.6-3.5 | 58.8% | 3.4-4.0 | 83.9% | 0.9 | 4.4 | 0.9 | 1.9 | 0.4 | 18.5 |
12-13 |
|
EU-2 | 12 | 26 | 10.1 | 1.9 | 2.5 | 2.3-5.3 | 1.3-3.8 | 38.5% | 1.8-2.3 | 81.5% | 0.8 | 1.1 | 1.0 | 1.8 | 0.1 | 7.8 |
13-14 |
|
EU-2 | 13 | 30 | 9.9 | 3.7 | 1.5 | 2.2-5.2 | 1.2-3.8 | 38.5% | 1.8-1.8 | 100.0% | 0.8 | 2.9 | 1.4 | 1.8 | 0.2 | 9.2 |
14-15 |
|
EU-2 | 15 | 24 | 8.7 | 2.8 | 1.3 | 1.9-3.9 | 0.8-3.0 | 38.5% | 2.6-3.3 | 78.0% | 0.6 | 2.2 | 0.6 | 1.3 | 0.0 | 7.2 |
19-20 |
|
BCL | 7 | 26 | 13.0 | 2.7 | 1.9 | 1.7-3.0 | 2.9-5.1 | 56.1% | 1.0-1.3 | 77.8% | 1.6 | 1.1 | 1.1 | 0.7 | 0.3 | 14.4 |
20-21 |
|
EU-2 | 20 | 22 | 10.1 | 2.4 | 1.7 | 1.2-2.4 | 2.1-4.7 | 46.1% | 1.6-2.0 | 79.5% | 0.7 | 1.7 | 0.8 | 1.3 | 0.1 | 9.6 |
21-22 |
|
EU-2 | 8 | 24 | 11.4 | 3.6 | 1.4 | 0.9-2.3 | 2.5-6.1 | 40.3% | 2.1-2.5 | 85.0% | 0.5 | 3.1 | 0.5 | 0.6 | 0.0 | 10.9 |
22-23 |
|
EU-1 | 17 | 10 | 3.2 | 0.7 | 0.5 | 0.4-1.2 | 0.6-1.8 | 34.0% | 0.6-0.7 | 83.3% | 0.1 | 0.6 | 0.4 | 0.4 | 0.0 | 2.4 |
Moyennes en compétitions internationales
Saison | Equipe | Ligue | MJ | Min | Pts | Reb | Pds | 2R-2T | 3R-3T | T% | LFR-LFT | LF% | Ro | Rd | IN | BP | CT | EVAL |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
16-17 |
|
Olympic-TQO | 4 | 21 | 12.3 | 3.8 | 1.3 | 2.8-5.3 | 1.0-2.8 | 46.9% | 3.8-4.0 | 93.8% | 1.3 | 2.5 | 2.3 | 2.3 | 0.0 | 12.8 |